ERBITUX in combination with encorafenib and FOLFOX is the first and only approved targeted regimen for the first-line treatment of adult patients with BRAF V600E-mutant mCRC
The approval is based on t......
VICTORIA, Seychelles, July 17, 2026 (GLOBE NEWSWIRE) -- Bitget, the world’s largest Universal Exchange (UEX), has launched the industry's first Cross-Asset Unified Account (UTA), bringing ......
